—GM
— • —
$76.42
P/E
30.36
PEG
—
FCF Yield
—
Rev Growth YoY
-129.0% YoY
Gross Margin
594.0%
Health Score
3/10
D/E Ratio
2.13
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers are absent from this data payload, which prevents a full company description. Based on available metrics — a current price of $76.42, a Price/Sales ratio of 0.37x, and a net margin of 146% — this appears to be a financial or specialty company operating in a capital-intensive market. Without a confirmed market cap figure, the capitalisation tier cannot be determined.
Financial Health
Score: 3/10
The financial picture is deeply contradictory and warrants caution. On one hand, the reported net margin of 146% and gross margin of 594% are extraordinary figures that likely reflect non-recurring items or accounting distortions rather than genuine operational strength — they should not be taken at face value...
Risk Assessment
- REVENUE COLLAPSE: Revenue growth of -129% year-over-year suggests revenues may have turned negative, indicating a fundamental disruption to the business model.
- EARNINGS DETERIORATION: Earnings growth of -4,974% year-over-year points to an extreme reversal in reported profitability versus the prior period.
- LEVERAGE: Debt/equity of 2.13x indicates a highly leveraged balance sheet with no free cash flow data available to confirm debt serviceability.
- VALUATION DISTORTION: EV/EBITDA of 100.9x is an extreme multiple that signals either near-zero EBITDA or significant enterprise value inflation from debt.
- DATA TRANSPARENCY: TTM Revenue, TTM Net Income, FCF, and market cap are all absent, making a complete fundamental assessment impossible.
---...
**Score: 3/10** The financial picture is deeply contradictory and warrants caution. On one hand, the reported net margin of 146% and gross margin of 594% are extraordinary figures that likely reflect non-recurring items or accounting distortions rather than genuine operational strength — they should not be taken at face value. On the other hand, the debt/equity ratio of 2.13x signals a heavily leveraged balance sheet, and the absence of free cash flow data makes it impossible to assess whether the company can service that debt from operations. The current ratio of 1.17x suggests only marginal short-term liquidity cushion. ---
- **REVENUE COLLAPSE:** Revenue growth of -129% year-over-year suggests revenues may have turned negative, indicating a fundamental disruption to the business model. - **EARNINGS DETERIORATION:** Earnings growth of -4,974% year-over-year points to an extreme reversal in reported profitability versus the prior period. - **LEVERAGE:** Debt/equity of 2.13x indicates a highly leveraged balance sheet with no free cash flow data available to confirm debt serviceability. - **VALUATION DISTORTION:** EV/EBITDA of 100.9x is an extreme multiple that signals either near-zero EBITDA or significant enterprise value inflation from debt. - **DATA TRANSPARENCY:** TTM Revenue, TTM Net Income, FCF, and market cap are all absent, making a complete fundamental assessment impossible. ---
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives